What is he best known for?
The fields of study he is best known for:
- Bacteria
- Internal medicine
- Antibiotics
The scientist’s investigation covers issues in Pseudomonas aeruginosa, Microbiology, Cystic fibrosis, Biofilm and Antibiotics.
His Pseudomonas aeruginosa study integrates concerns from other disciplines, such as Chronic infection, Colistin and Virulence.
His Microbiology research is multidisciplinary, incorporating perspectives in Quorum sensing, Pseudomonadaceae, Immune system and Bacteria.
His biological study spans a wide range of topics, including Respiratory disease, Lung, Sputum and Immunology.
His work deals with themes such as In vitro, Antimicrobial, Chronic disease, Innate immune system and In vivo, which intersect with Biofilm.
He combines subjects such as Combination therapy, Drug resistance and Intensive care medicine with his study of Antibiotics.
His most cited work include:
- Antibiotic resistance of bacterial biofilms (1802 citations)
- Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors (1089 citations)
- Inhibition of quorum sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone compound. (786 citations)
What are the main themes of his work throughout his whole career to date?
Niels Høiby mostly deals with Microbiology, Pseudomonas aeruginosa, Cystic fibrosis, Immunology and Biofilm.
Niels Høiby is interested in Antibiotics, which is a branch of Microbiology.
His studies in Pseudomonas aeruginosa integrate themes in fields like Quorum sensing, Ciprofloxacin, Inflammation and Chronic infection, Immune system.
His Cystic fibrosis study which covers Lung that intersects with Pneumonia.
His research integrates issues of Tobramycin, Antimicrobial and In vivo in his study of Biofilm.
His Internal medicine research integrates issues from Gastroenterology, Surgery and Staphylococcus aureus.
He most often published in these fields:
- Microbiology (64.84%)
- Pseudomonas aeruginosa (62.35%)
- Cystic fibrosis (48.76%)
What were the highlights of his more recent work (between 2014-2021)?
- Pseudomonas aeruginosa (62.35%)
- Microbiology (64.84%)
- Cystic fibrosis (48.76%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Pseudomonas aeruginosa, Microbiology, Cystic fibrosis, Biofilm and Antibiotics.
His Pseudomonas aeruginosa study is related to the wider topic of Bacteria.
His work carried out in the field of Microbiology brings together such families of science as Wound healing and In vivo.
His Cystic fibrosis research incorporates elements of Gastroenterology, Paranasal sinuses, Antibody and Lung.
His research in Biofilm intersects with topics in Inflammation, Chronic wound, Mucus and Pseudomonas.
The Antibiotics study combines topics in areas such as Adjuvant, Pathogen, Multidrug tolerance and Intensive care medicine.
Between 2014 and 2021, his most popular works were:
- Strategies for combating bacterial biofilm infections (375 citations)
- ESCMID∗ guideline for the diagnosis and treatment of biofilm infections 2014 (355 citations)
- Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. (153 citations)
In his most recent research, the most cited papers focused on:
- Bacteria
- Internal medicine
- Antibiotics
His primary scientific interests are in Microbiology, Pseudomonas aeruginosa, Biofilm, Cystic fibrosis and Antibiotics.
Niels Høiby interconnects Guideline and Innate immune system in the investigation of issues within Microbiology.
Pseudomonas aeruginosa is a subfield of Bacteria that Niels Høiby investigates.
His work on Biofilm matrix as part of general Bacteria research is frequently linked to Penetration, bridging the gap between disciplines.
His Biofilm research incorporates themes from Staining, Mutant, Intensive care medicine, Clinical microbiology and Pseudomonas.
He has researched Cystic fibrosis in several fields, including Phenotype, Oxidative stress and Lung, Lung infection.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
